Stimac Danijela, Vukusić Ivan, Culig Josip, Sostar Zvonimir, Bucalić Mila
Department of Pharmacoepidemiology, Zagreb Institute of Public Health, Zagreb, Croatia.
Coll Antropol. 2009 Mar;33(1):237-43.
The aim was to estimate outpatient consumption of psychotropic drugs in Croatia in correlation with Scandinavian countries. Data on drug utilization, from Zagreb Municipal Pharmacy, were used to calculate the number of defined daily doses (DDD) and DDD per 1000 inhabitants per day (DDD/TID) using Anatomical-Therapeutic-Chemical methodology (ATC) by WHO. Data of the Nordic Medico-Statistical Committee were used for Scandinavian countries. In Zagreb, total utilization of psychopharmaceuticals of 144.9 DDD/TID in 2001, 148.9 DDD/TID in 2002 and 141.9 DDD/TID in 2003. The anxiolytic/antidepressant ratio decreased in Zagreb by 35.19% (7.19 in 2001 and 4.66 in 2003), whereas in Scandinavian countries it showed a constant rate (0.7 in Finland, 0.4 in Denmark and Norway, and 0.3 in Sweden). The three-year utilization patterns show that Croatia has been ever more closely following Scandinavian countries although there have been a notable differences between Croatia and Scandinavian countries.
目的是评估克罗地亚精神药物的门诊消费量，并与斯堪的纳维亚国家进行对比。来自萨格勒布市药房的药物使用数据，采用世界卫生组织的解剖治疗化学方法（ATC），用于计算限定日剂量（DDD）数量以及每千居民每日限定日剂量数（DDD/TID）。斯堪的纳维亚国家的数据采用北欧医学统计委员会的数据。在萨格勒布，2001年精神药物的总使用量为144.9 DDD/TID，2002年为148.9 DDD/TID，2003年为141.9 DDD/TID。萨格勒布的抗焦虑/抗抑郁药物比例下降了35.19%（2001年为7.19，2003年为4.66），而在斯堪的纳维亚国家该比例保持稳定（芬兰为0.7，丹麦和挪威为0.4，瑞典为0.3）。三年的使用模式表明，克罗地亚一直更加紧密地追随斯堪的纳维亚国家，尽管克罗地亚和斯堪的纳维亚国家之间存在显著差异。
